Sort
48,018 grants matching “immunotherapy”
Prebiotic diet intervention to enhance the microbiome and immunotherapy response in melanoma
$678,399Carrie Daniel-Macdougall · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
3D Microscopy with Ultraviolet Surface Excitation (3D-MUSE)
$678,327David L Wilson · Case Western Reserve University · R01 · FY2020 · EB
Functional Characterization and Development of Therapeutic Paradigms for DNA Damage Repair (DDR)-deficient Lethal Prostate Cancer
$678,271Goutam Chakraborty · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
Molecular subtyping of brain tumors using a blood-based multiplexed assay
$678,228Leonora Balaj · Massachusetts General Hospital · R01 · FY2025 · CA
Mechanistic Core
$678,210Lloyd F Mayer · Icahn School Of Medicine At Mount Sinai · U19 · FY2014 · AI
Selective treatment of acute myeloid leukemia with radioimmunotherapies targeting the active conformation of integrin beta-2
$678,101Arun P. Wiita · University Of California, San Francisco · R01 · FY2025 · CA
ENHANCING EFFICACY OF THE PD1 PD-L1 INHIBITOR-MEDIATED ANTI LIVER CANCER IMMUNOTHERAPY
$677,998Icahn School Of Medicine At Mount Sinai · · FY2016 · Department of Defense
Structure-guided and epitope-based design of potent and broadly neutralizing nanobodies for COVID-19 mucosal immunotherapy
$677,986Lisa A. Cavacini · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · AI
Antidepressant regulation of PDAC
$677,974Valerie Marie Weaver · University Of California, San Francisco · U01 · FY2025 · CA
Pathobiology of ANCA Glomerulonephritis: Targeting Adaptive and Innate Immune Processes for Precision Therapies
$677,829Ronald J Falk · Univ Of North Carolina Chapel Hill · R01 · FY2021 · DK
Project 2: Durable impact of HCV on innate and adaptive immunity
$677,806Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2025 · AI
Aire-expressing macrophages as novel mediators of tumor immune evasion
$677,787James Morgan Gardner · University Of California, San Francisco · R37 · FY2025 · CA
Immunotherapy of inflammation, autoimmune disease and cancer
$677,722Wanjun Chen · National Institute Of Dental & Craniofacial Research · ZIA · FY2024 · DE
MICRORNA REGULATION OF ADIPOSE TISSUE IMMUNE RESPONSE IN OBESITY
$677,629Huaizhu Wu · Baylor College Of Medicine · R01 · FY2024 · DK
BAFF-R CAR T cell therapy for ALL
$677,623Xiuli Wang · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
BAFF-R CAR T cell therapy for ALL
$677,623Larry W Kwak · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
Mechanistic Virology Core
$677,607Kartik Chandran · Scripps Research Institute, The · U19 · FY2015 · AI
Adoptive Transfer of MART-1 TCR Engineered Cells after a Myelodepleting Regimen
$677,575Antoni Ribas · California Institute Of Technology · P01 · FY2011 · CA
Using artificial intelligence to discover spatial, genomic, and pathologic biomarkers to guide and augment immune checkpoint inhibitor therapy for gastric cancer
$677,533Sam C. Wang · Ut Southwestern Medical Center · R01 · FY2024 · CA
Dissecting the role of CD8+ T cells in atherosclerosis
$677,514Chiara Giannarelli · New York University School Of Medicine · R01 · FY2021 · HL
Targeting novel therapeutic vulnerabilities in LKB1 mutant tumors.
$677,471Nabeel Bardeesy · Massachusetts General Hospital · R01 · FY2020 · CA
Targeting novel therapeutic vulnerabilities in LKB1 mutant tumors.
$677,442Nabeel Bardeesy · Massachusetts General Hospital · R01 · FY2021 · CA
TLR5 enhancement of liver-directed radiotherapy plus immune checkpoint blockade against irradiated liver metastasis and abscopal tumors
$677,410Craig M. Brackett · Roswell Park Cancer Institute Corp · R01 · FY2024 · CA
Tissue-based biomarkers of anti-PD-1-based therapy in metastatic renal cell carcinoma
$677,362Toni Choueiri · Dana-Farber Cancer Inst · R01 · FY2024 · CA
Career Development in Pediatric and Medical Oncology
$677,301Soheil Meshinchi · Fred Hutchinson Cancer Center · K12 · FY2024 · CA